Perspective Therapeutics Inc (CATX)
EBITDA Growth
-20.94%
Quarterly · Period ending:
CATX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-20.94%period ending
Latest reported-20.94%period ending
CATX Quarterly EBITDA YoY % (100.00% → -20.94%)
Year-over-year change
High-resolution chart · PNG
CATX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -20.9391% | |
| -51.687% | |
| 10.5964% | |
| -74.7011% | |
| -70.0877% | |
| -90.5684% | |
| -384.8322% | |
| -32.9513% | |
| -30.9978% | |
| 14.6466% | |
| -190.4907% | |
| -161.3285% | |
| -365.0171% | |
| -738.872% | |
| -87.619% | |
| -86.9074% | |
| -94.196% | |
| -80.2198% | |
| -93.9655% | |
| -225.7353% | |
| 9.0043% | |
| -42.1875% | |
| 6.0185% | |
| 14.787% | |
| -0.9615% | |
| 56.0515% | |
| 41.4237% | |
| 46.2988% | |
| 51.4843% | |
| 11.6755% | |
| -0.4768% | |
| 3.1291% | |
| -27.1845% | |
| 3.7929% | |
| -1.2414% | |
| 3.2787% | |
| -62.0442% | |
| -1,093.4783% | |
| -1,158.3942% | |
| -1,257.6642% | |
| -3.7521% | |
| 116.2739% | |
| 116.8558% | |
| 114.9166% | |
| 4.9878% | |
| -8.54% | |
| 8.2696% | |
| 13.1786% | |
| -37.3113% | |
| -20.4986% | |
| 3.433% | |
| -1.1898% | |
| -60.1778% | |
| 15.5955% | |
| -24.0949% | |
| -18.0576% | |
| -84.7668% | |
| -148.5885% | |
| 34.6931% | |
| -37.512% | |
| 64.3229% | |
| 63.8983% | |
| -60.994% | |
| 1.2813% | |
| 15.3094% | |
| 27.5626% | |
| 68.2528% | |
| 45.4429% | |
| 7.3836% | |
| 30.3506% | |
| 14.5% | |
| 44.6439% | |
| 59.4343% | |
| 11.0536% | |
| -45.8665% | |
| 22.4491% | |
| 0.001% | |
| -76.8023% | |
| -47.85% | |
| -62.9257% | |
| -1,162.3103% | |
| -1,101.0983% | |
| -40,904.2696% | |
| 6,474.9529% | |
| 4,189.9796% | |
| 100% |